查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1468398

2024-2032年按藥物類型（化療、生物療法、荷爾蒙療法等）、配銷通路（醫院藥房、藥房和零售藥房、線上藥房）和地區分類的前列腺癌治療市場報告

Prostate Cancer Treatment Market Report by Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球前列腺癌治療市場規模達77億美元。

前列腺癌是一種嚴重的惡性腫瘤，是由男性前列腺內的各種異常細胞無法控制的分裂和擴張引起的。它可以透過使用各種療法來治療，例如疫苗、藥物和治療。其中，化療、免疫療法、冷凍療法、手術、荷爾蒙療法、標靶療法和放射療法是一些最常見的治療類型，有助於減輕癌細胞在體內的擴散。這些治療是根據各種評估提供給患者的，例如患者的年齡、所經歷症狀的嚴重程度、醫療狀況和既往健康史。

前列腺癌治療市場趨勢：

攝護腺癌的盛行率不斷上升，特別是在不斷增加的老年人口中，是目前推動市場成長的主要因素之一。與此一致的是，有利的醫療報銷政策的可用性以及一些國家的政府機構為引入患者援助計劃（PAP）而採取的眾多舉措正在成為其他成長誘導因素。 PAP 是一項有組織的計劃，由製藥公司控制，透過提供免費治療藥物來向患者提供經濟援助。此外，重大技術進步，例如將多參數磁振造影（mp-MRI）設備與非轉移性去勢抗性（nmCRPC）和轉移性荷爾蒙天然（mHNPC）設定相結合，用於早期檢測前列腺癌，同時減輕診斷錯誤，也促進了市場的成長。此外，為引進新型治療產品而對研發（R&D）活動進行的廣泛投資，以及這些產品在各種線上和線下配銷通路上的便捷獲取，正在為市場創造積極的前景。

本報告回答的關鍵問題

  • 2023年全球攝護腺癌治療市場規模有多大？
  • 2024-2032年全球前列腺癌治療市場的預期成長率是多少？
  • 推動全球前列腺癌治療市場的關鍵因素是什麼？
  • COVID-19 對全球前列腺癌治療市場有何影響？
  • 根據藥物類型，全球前列腺癌治療市場的細分如何？
  • 全球前列腺癌治療市場按配銷通路分類是怎樣的？
  • 全球前列腺癌治療市場的關鍵區域有哪些？
  • 全球前列腺癌治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球前列腺癌治療市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依藥物類型

  • 化療
    • 市場走向
    • 市場預測
  • 生物療法
    • 市場走向
    • 市場預測
  • 荷爾蒙療法
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 藥局和零售藥局
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Astellas Pharma Inc.
    • AstraZeneca plc
    • Bayer Aktiengesellschaft
    • Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)
    • F. Hoffmann-La Roche AG
    • Ferring BV
    • GlaxoSmithKline Plc
    • Ipsen (Mayroy SA)
    • Novartis International AG
    • Takeda Pharmaceutical Company Ltd.
    • Tolmar Pharmaceuticals Inc.
Product Code: SR112024A6185

The global prostate cancer treatment market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.

Prostate cancer is a type of severe malignant tumor, which is caused by the uncontrollable division and expansion of various abnormal cells in the prostate gland present in men. It can be treated through the use of various therapeutics, such as vaccines, medications, and treatments. Amongst these, chemotherapy, immunotherapy, cryotherapy, surgery, hormonal, targeted and radiation therapy are some of the most common treatment types that aid in mitigating the spread of cancer cells in the body. These therapies are provided to the patient based on various assessments, such as the age of the patient, severity of the symptoms experienced, medical condition, and previous health history.

Prostate Cancer Treatment Market Trends:

The increasing prevalence of prostate cancer, especially amongst the rising geriatric population, is one of the prime factors currently driving the market toward growth. In line with this, the availability of favorable medical reimbursement policies and the numerous initiatives being undertaken by the government bodies of several countries for introducing patient assistance programs (PAPs) are acting as other growth-inducing factors. PAP is an organized program, which is controlled by pharmaceutical companies for providing financial assistance to patients by offering free medications for treatment purposes. Moreover, significant technological advancements, such as the integration of multiparametric-magnetic resonance imaging (mp-MRI) devices with non-metastatic castration-resistant (nmCRPC) and metastatic hormone nave (mHNPC) settings for detecting prostate cancer at early stages, while mitigating diagnostic errors, is also contributing to the market growth. Additionally, extensive investments in the research and development (R&D) activities to introduce novel therapeutic products, along with their easy availability across various online and offline distribution channels, are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global prostate cancer treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug type and distribution channel.

Breakup by Drug Type:

Chemotherapy

Biological Therapy

Hormone Therapy

Others

Breakup by Distribution Channel:

Hospitals Pharmacies

Drug Stores and Retail Pharmacies

Online Pharmacies

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., AstraZeneca plc, Bayer Aktiengesellschaft, Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.), F. Hoffmann-La Roche AG, Ferring B.V., GlaxoSmithKline Plc, Ipsen (Mayroy SA), Novartis International AG, Takeda Pharmaceutical Company Ltd. and Tolmar Pharmaceuticals Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global prostate cancer treatment market in 2023?
  • 2. What is the expected growth rate of the global prostate cancer treatment market during 2024-2032?
  • 3. What are the key factors driving the global prostate cancer treatment market?
  • 4. What has been the impact of COVID-19 on the global prostate cancer treatment market?
  • 5. What is the breakup of the global prostate cancer treatment market based on drug type?
  • 6. What is the breakup of the global prostate cancer treatment market based on the distribution channel?
  • 7. What are the key regions in the global prostate cancer treatment market?
  • 8. Who are the key players/companies in the global prostate cancer treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prostate Cancer Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Chemotherapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biological Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hormone Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospitals Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Drug Stores and Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Astellas Pharma Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 AstraZeneca plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bayer Aktiengesellschaft
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Ferring B.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 GlaxoSmithKline Plc
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Ipsen (Mayroy SA)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Novartis International AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Takeda Pharmaceutical Company Ltd.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Tolmar Pharmaceuticals Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Prostate Cancer Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Prostate Cancer Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Prostate Cancer Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Prostate Cancer Treatment Market: Breakup by Drug Type (in %), 2023
  • Figure 5: Global: Prostate Cancer Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Prostate Cancer Treatment Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Prostate Cancer Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Prostate Cancer Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Prostate Cancer Treatment (Biological Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Prostate Cancer Treatment (Biological Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Prostate Cancer Treatment (Hormone Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Prostate Cancer Treatment (Hormone Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Prostate Cancer Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Prostate Cancer Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Prostate Cancer Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Prostate Cancer Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: North America: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: North America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: United States: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: United States: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Canada: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Canada: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Asia-Pacific: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Asia-Pacific: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: China: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: China: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Japan: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Japan: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: India: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: India: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: South Korea: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: South Korea: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Australia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Australia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Indonesia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Indonesia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Europe: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Europe: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Germany: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Germany: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: France: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: France: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: United Kingdom: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: United Kingdom: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Italy: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Italy: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Spain: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Spain: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Russia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Russia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Latin America: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Latin America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Brazil: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Brazil: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Mexico: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Mexico: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Middle East and Africa: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Middle East and Africa: Prostate Cancer Treatment Market: Breakup by Country (in %), 2023
  • Figure 69: Middle East and Africa: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Global: Prostate Cancer Treatment Industry: SWOT Analysis
  • Figure 71: Global: Prostate Cancer Treatment Industry: Value Chain Analysis
  • Figure 72: Global: Prostate Cancer Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prostate Cancer Treatment Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Prostate Cancer Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 3: Global: Prostate Cancer Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Prostate Cancer Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Prostate Cancer Treatment Market: Competitive Structure
  • Table 6: Global: Prostate Cancer Treatment Market: Key Players